
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year. - 2
Figure out How to Store Your Gold Ventures: A Thorough Aide safely - 3
Supportive Tips On Home loans For First-Time Home Purchasers - 4
Travel Through France's Most Iconic Wine Regions By Train On An Immersive Seven-Day Journey - 5
'Supergirl' drops 1st teaser trailer: Watch Milly Alcock as Kara Zor-El and the return of Krypto the Superdog
The Most Vital Crossroads in Olympic History
Tech Patterns: Contraptions That Will Shape What's in store
The Main 20 Gaming Control center Ever
2023's Best 10 Cell phone Advancements You Can't Miss
As tetanus vaccination rates decline, doctors worry about rising case numbers
Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
The secret appeal of Harlan Coben’s messy, addictive TV thrillers
Watch SpaceX launch powerful ocean-mapping satellite for Europe and NASA early Nov. 17
Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals












